-+ 0.00%
-+ 0.00%
-+ 0.00%

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga·11/14/2024 21:10:05
Listen to the news

Gainers

  • Serina Therapeutics (AMEX:SER) shares moved upwards by 33.8% to $6.69 during Thursday's pre-market session. The market value of their outstanding shares is at $59.4 million. As per the press release, Q3 earnings came out 2 days ago.
  • Tivic Health Systems (NASDAQ:TIVC) shares moved upwards by 18.3% to $0.39. The company's market cap stands at $2.4 million. As per the press release, Q3 earnings came out today.
  • Venus Concept (NASDAQ:VERO) shares rose 16.98% to $0.39. The company's market cap stands at $2.8 million. As per the news, the Q3 earnings report came out yesterday.
  • FibroBiologics (NASDAQ:FBLG) stock increased by 16.23% to $3.58. The company's market cap stands at $126.2 million. As per the news, the Q3 earnings report came out 2 days ago.
  • Adial Pharmaceuticals (NASDAQ:ADIL) stock increased by 13.01% to $1.12. The company's market cap stands at $7.1 million. The company's, Q3 earnings came out yesterday.
  • Astria Therapeutics (NASDAQ:ATXS) shares increased by 11.96% to $11.88. The company's market cap stands at $670.3 million. The company's, Q3 earnings came out yesterday.

Losers

  • Nuvectis Pharma (NASDAQ:NVCT) shares fell 52.4% to $5.08 during Thursday's pre-market session. The company's market cap stands at $98.1 million.
  • icad (NASDAQ:ICAD) stock fell 23.08% to $1.8. The company's market cap stands at $47.4 million. The company's, Q3 earnings came out yesterday.
  • OptimizeRx (NASDAQ:OPRX) stock fell 22.77% to $4.75. The company's market cap stands at $87.0 million. The company's, Q3 earnings came out yesterday.
  • PDS Biotechnology (NASDAQ:PDSB) shares fell 19.79% to $2.21. The company's market cap stands at $81.3 million. The company's, Q3 earnings came out today.
  • Harrow (NASDAQ:HROW) shares decreased by 18.92% to $42.0. The company's market cap stands at $1.4 billion. As per the press release, Q3 earnings came out yesterday.
  • Calidi Biotherapeutics (AMEX:CLDI) shares decreased by 17.76% to $2.78. The market value of their outstanding shares is at $32.4 million. As per the press release, Q3 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.